首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Trabecular meshwork bypass tube shunt: initial case series
【2h】

Trabecular meshwork bypass tube shunt: initial case series

机译:小梁网旁路管分流器:初始案例系列

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Aims: This study describes a prospective consecutive case series of the initial six eyes of five patients undergoing implantation of the trabecular bypass tube shunt.>Methods: A prospective consecutive case series. The initial six eyes of five patients with uncontrolled open angle glaucoma who had never previously undergone ocular surgery. Implantation of the trabecular bypass tube shunt measuring 150 μm outer diameter and 50 μm inner diameter was performed with the distal end placed in Schlemm’s canal and the proximal end in the anterior chamber. The main outcome measures were visual acuity, intraocular pressure, glaucoma medication use.>Results: The tube was successfully implanted in five of six eyes. In four eyes longer term follow up of 5–9 months showed no loss of visual acuity with decreased intraocular pressure from preoperative levels (mean 23.4–16.5 mm Hg) and reduced requirement of glaucoma medications (mean 3–0.5). In a subset of two eyes, there was no measured increase in aqueous flare or reduction of endothelial cell count. In one eye the tube was explanted because of presumed misplacement by excessive bleeding during surgery. Two eyes showed a diffuse bleb.>Conclusions: This study reports the initial experience with a novel approach to surgical glaucoma therapy. This very small tube allows a direct communication to be established between the anterior chamber and Schlemm’s canal, effecting a trabecular bypass. In this small number of eyes this procedure reduced intraocular pressure and the need for glaucoma medications without appreciable side effects.
机译:>目的:该研究描述了5名接受小梁旁路分流术植入的患者的最初6只眼的连续病例。>方法:连续病例。 5例从未接受过眼科手术的失控开角型青光眼患者的最初6眼。植入的小梁旁路分流管的外径为150μm,内径为50μm,远端置于Schlemm根管中,近端置于前房中。主要预后指标为视力,眼压,青光眼用药。>结果:该管已成功植入六只眼中的五只眼。在四只眼中,长期随访5–9个月并未显示视力下降,术前水平的眼内压降低(平均23.4–16.5 mm Hg),青光眼药物需求减少(平均3–0.5)。在两只眼睛的一个子集中,未见房水耀斑增加或内皮细胞计数减少。一只眼睛的管由于手术过程中过多的出血而被放错了位置。两只眼睛显示出弥漫性气泡。>结论:该研究报告了一种新颖的手术性青光眼治疗方法的初步经验。这种非常小的管子可以在前房和Schlemm的管之间建立直接连通,从而实现小梁旁路。在这种少量的眼睛中,该手术降低了眼内压,并且无需明显的副作用即可使用青光眼药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号